Ensign Peak Advisors, Inc Alkermes Plc. Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 460,300 shares of ALKS stock, worth $14.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
460,300
Previous 62,916
631.61%
Holding current value
$14.3 Million
Previous $1.81 Million
740.19%
% of portfolio
0.03%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ALKS
# of Institutions
395Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$904 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$575 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$312 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$255 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$199 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.1B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...